About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 176 record(s)
Req # A-2021-001318
A screenshot or printout of the database showing communications between Sona Nanotech and Health Canada related to their submission for an Interim Order for the use of its COVID-19 rapid detection, point of care, antigen test. Time period: January 1, 2020 to December 31, 2020.Organization: Health Canada
May 2022
Req # A-2021-001547
ArriveCAN Information Sharing Agreement with Canada Border Services Agency (CBSA).Organization: Health Canada
May 2022
Req # A-2021-001773
The number of rapid tests from the federal government distributed to each province for each month and each type of product since September 2020.Organization: Health Canada
May 2022
Req # A-2021-002102
A list of all authorized clinical trial applications submitted from January 2015 to March 22, 2022.Organization: Health Canada
May 2022
Req # A-2021-002139
For the following selection processes: 21-NHW-HECS-EA-NCR-322299, 22-NHW-ROEB-EA-NCR-327929, 21-NHW-ROEB-IA-NCR-319133a, 21-NHW-HPFB-IA-NCR-322996, 21-NHW-PMRA-EA-NCR-323294, 22-NHW-HPFB-INA-NCR-331790. The number of applicants, number of candidates invited to an exam assessment, number of candidates invited for an interview assessment, number of candidates who passed the selection interview assessment, number of candidates placed in a pool, by type of pool, number of referrals or appointments made from pool and the Volume Management strategies employed.Organization: Health Canada
May 2022
Req # A-2022-000036
Access to all documentation related to authorizations, complaints, offence notices, recalls and inspections that may be held by or under the control of your agency in relation to the company 2573486 Ontario Inc. For the last 10 years.Organization: Health Canada
May 2022
Req # A-2020-001333
Adverse Drug Reactions (ADRs). Report numbers: E2B_02759931, E2B_02759940, E2B_02759941, E2B_02759943, E2B_02759944, E2B_02759947, E2B 02759950, E2B_02759958, E2B_02759961, E2B_02759963, E2B_02759965, E2B_02759966, E2B_02759968, E2B_02759969, E2B_02759972, E2B_02759975, E2B 02759978, E2B_02759979, E2B_02759981, E2B_02759983.Organization: Health Canada
May 2022
Req # A-2021-000281
Adverse Drug Reaction (ADR) for Leflunomide. Report number: E2B_03706173.Organization: Health Canada
May 2022
Req # A-2021-001778
Adverse Drug Reactions (ADRs) for ALFUZOSIN HYDROCHLORIDE. Report numbers: E2B_04302067, E2B_04354452.Organization: Health Canada
May 2022
Req # A-2021-001862
Adverse Drug Reaction (ADR) for DESOXIMETASONE. Report number: E2B_04489811.Organization: Health Canada
May 2022